Ventrus Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.ventrusbio.com
Clinical Trials
7
Active:0
Completed:3
Trial Phases
3 Phases
Phase 1:4
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (57.1%)Phase 3
2 (28.6%)Phase 2
1 (14.3%)Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects
Phase 1
Completed
- Conditions
- CLARITHROMYCIN/DILTIAZEM [VA Drug Interaction]
- Interventions
- First Posted Date
- 2014-03-06
- Last Posted Date
- 2014-04-14
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT02080780
- Locations
- 🇺🇸
TKL Research, Paramus, New Jersey, United States
A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design
Phase 1
- Conditions
- Skin Irritation
- Interventions
- Drug: Vehicle CreamDrug: 0.1% solution o sodium lauryl sulfate (SLS)Drug: Saline 0.9%
- First Posted Date
- 2013-03-29
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 30
- Registration Number
- NCT01821274
- Locations
- 🇺🇸
TKL Research, Paramus, New Jersey, United States
An Open-Label, Single- and Multi-Dose Pharmacokinetic (PK) Study of Oral Diltiazem and Topical Diltiazem Hydrochloride
Phase 1
- Conditions
- Adult Subjects With Anal Fissures.
- Interventions
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 12
- Registration Number
- NCT01816191
- Locations
- 🇺🇸
Wake Research Associates, Raleigh, North Carolina, United States
Topical Safety Study of Topical Diltiazem Hydrochloride
Phase 1
- Conditions
- Diltiazem Skin Sensitivity.
- Interventions
- Drug: Saline (0.9%)Drug: Vehicle CreamDrug: 0.1% solution of sodium lauryl sulfate (SLS)
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 200
- Registration Number
- NCT01816529
- Locations
- 🇺🇸
TKL Research, Paramus, New Jersey, United States
Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2014-01-23
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 434
- Registration Number
- NCT01690221
- Locations
- 🇺🇸
The Crawford Clinic, Anniston, Alabama, United States
🇺🇸Surgical Association of Mobile, Mobile, Alabama, United States
🇺🇸University of South Alabama, Mobile, Alabama, United States
- Prev
- 1
- 2
- Next
News
No news found